ASTH vs PRVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

ASTH

48.9
AI Score
VS
PRVA Wins

PRVA

62.1
AI Score

Investment Advisor Scores

ASTH

49score
Recommendation
HOLD

PRVA

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ASTH PRVA Winner
Net Income 24.00M 12.11M ASTH
Operating Income 78.53M 19.20M ASTH
ROE 3.1% 1.5% ASTH
ROA 1.1% 0.8% ASTH
Total Assets 2.22B 1.49B ASTH
Cash 429.47M 412.20M ASTH
Current Ratio 1.40 1.62 PRVA
Free Cash Flow 104.49M -48.48M ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: +6.1% · 3M: -4.7% PRVA 1M: -5.2% · 3M: -12.6%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $37.98

PRVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.2%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $20.42

Fundamentals Snapshot

Metric ASTH PRVA
Market Cap
Forward P/E 10.7 19.2
Trailing P/E 46.4 92.6
Revenue (TTM)
Revenue Growth 0.5% 0.2%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 0.82 0.22
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PRVA is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.